Back
Neurocrine Biosciences 10K Form
Buy
68
NBIX
Neurocrine Biosciences
Last Price:
$139.06
Seasonality Move:
9.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-01 | 10Q | NBIX/Neurocrine Biosciences Quarterly |
| 2023-10-31 | 10Q | NBIX/Neurocrine Biosciences Quarterly |
| 2023-08-01 | 10Q | NBIX/Neurocrine Biosciences Quarterly |
| 2023-05-03 | 10Q | NBIX/Neurocrine Biosciences Quarterly |
| 2022-11-01 | 10Q | NBIX/Neurocrine Biosciences Quarterly |
| 2022-08-04 | 10Q | NBIX/Neurocrine Biosciences Quarterly |
Receive NBIX News And Ratings
See the #1 stock for the next 7 days that we like better than NBIX
NBIX Financial Statistics
Sales & Book Value
| Annual Sales: | $1.9B |
|---|---|
| Cash Flow: | $149.9M |
| Price / Cash Flow: | 32.7 |
| Annual Sales: | $26.87 |
| Price / Book: | 5.18 |
Profitability
| EPS (TTM): | 3.73000 |
|---|---|
| Net Income (TTM): | $385.9M |
| Gross Margin: | $1.8B |
| Return on Equity: | 16.29% |
| Return on Assets: | 11.76% |
Neurocrine Biosciences Earnings Forecast
Key Neurocrine Biosciences Financial Ratios
-
The Gross Profit Margin over the past 28 years for NBIX is 97.90%.
-
The Selling, General & Administrative Expenses for NBIX have been equal to 47.04% of Gross Profit Margin.
-
The Research & Development expenses have been 29.94% of Revenue.
-
The Interest Expense is 1.84% of Operating Income.
-
The Net Earning history of NBIX is 13.23% of Total Revenues.
-
Per Share Earnings over the last 28 years have been positive in 13 years.
Neurocrine Biosciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | NBIX |
| CUSIP: | 64125C |
| Website: | neurocrine.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.37 |
| Quick Ratio: | 3.98 |
Price-to-Earnings
| Trailing P/E Ratio: | 56.29 |
|---|---|
| Forward P/E Ratio: | 18.51 |
NBIX Technical Analysis vs Fundamental Analysis
Buy
68
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences a Buy or a Sell?
-
Neurocrine Biosciences stock is rated a BuyThe current Neurocrine Biosciences [NBIX] share price is $139.03. The Score for NBIX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.